AMSTERDAM—Philips will pay $1.1 billion to settle the personal injury litigation and the medical monitoring class action lawsuit to end the uncertainty associated with litigation in the U.S.
AMSTERDAM—Philips Respironics announced the discontinuation of 19 sleep and respiratory products in the United States with a shift in focus to the sale of consumables and accessories, including masks.
Philips Respironics provided the latest results and conclusions on the comprehensive test and research program to assess potential health risks related to the polyester-based polyurethane (PE-PUR) sound abatement foam in specific sleep therapy and ventilator devices under the voluntary June 2021 recall notification/field safety notice.*
AMSTERDAM—Philips Respironics has released updated results of testing on its recalled PAP and ventilation devices to the Food and Drug Administration, saying that the assessments available show patients exposed to chemicals and particulates by using them were unlikely to have appreciable harm to their health.
WASHINGTON—More than $1.7 billion in False Claims Act settlements and judgments reported by the Department of Justice in fiscal year 2022 were associated with the health care industry, including homecare sectors such as home health, durable medical equipment (DME) and medical device manufacturers.
AMSTERDAM (July 5, 2022)—A sampling of recalled CPAP devices showed significant foam degradation when ozone cleaning was used, said Philips Respironics in an update on its test and research program on polyester-based polyurethane (PE-PUR) sound abatement foam used in specific CPAP, BiPAP and mechanical ventilator devices. On June 14, 2021, Philips Respironics initiated a voluntary recall notification/field safety notice to address potential health risks related to the foam.
PHOENIX, Arizona (July 14, 2021)—Home medical equipment providers may need to wait as long as a year before the situation is back to normal on Philips Respironics CPAP devices, which have been put on hold due to a nationwide recall, according to the American Association for Homecare.
LAS VEGAS, Nev. (March 6, 2020)--Robotic pets designed for an aging population were the big winner at the New Product Pavilion Providers' Choice Awards at Medtrade Spring.
The awards, which HomeCare sponsors, are given based on attendee voting at the event at the Mandalay Bay Convention Center in Las Vegas.
LAS VEGAS and AMSTERDAM (April 18, 2019)—Royal Philips, a provider of health technology, introduced new solutions and services at Medtrade Spring 2019. During the show, Philips featured its latest offerings designed to further enhance effective and efficient care for patients with chronic respiratory and sleep conditions. These include the new, patient-focused DreamStation Go Heated Humidifier and DreamWisp, as well as the recent two-way integration of resupply with NikoHealth.
AMSTERDAM (January 17, 2019)—Royal Philips, a provider of health technology, announced the company has sold its 10 millionth DreamWear CPAP mask and interchangeable cushion. As part of the Dream Family, DreamWear is a mask frame that accommodates multiple cushions, places the hose on top of the head and is designed to prevent red marks, discomfort and irritation on the nose bridge.
AMSTERDAM and PARIS (September 14, 2018)—At the European Respiratory Society (ERS) International Congress 2018 in Paris, France (September 15–19), Royal Philips a provider of health technology, will showcase the company’s growing portfolio of advanced connected care solutions designed to foster effective and efficient care for chronic respiratory and sleep conditions.
LAS VEGAS (March 27, 2018)—At Medtrade Spring in Las Vegas, Nevada (March 27-29), Royal Philips, a provider of health technology, announced the launch of DreamWear Full face, the third mask option available for its award-winning DreamWear mask system. Philips Respironics used the company’s proprietary design tools to analyze facial data from thousands of 3D scans to create a design that prevents red marks, discomfort, and irritation on the nose bridge.
AMSTERDAM (March 12, 2018)—Ahead of World Sleep Day on March 16, Royal Philips, a provider in health technology, has released the findings from its annual global survey in the report, “Better Sleep, Better Health. A Global Look at Why We’re Still Falling Short on Sleep,” which looked at what keeps people in 13 countries from getting their optimal night’s rest.
TUCSON, Ariz. (July 10, 2017)—COPD hospitalizations are at an all-time high. The 30-day readmission rate for patients ranges from 20 to 39 percent, with related health care costs at an estimated $50 billion. A recently published study, funded by Royal Philips, revealed that although positive airway pressure (PAP) therapy was associated with a reduction in hospitalization, more than 92 percent of patients studied were not receiving it in any form.
AMSTERDAM, the Netherlands (April 11, 2017)—Royal Philips announced the launch of DreamStation Go, its newest and smallest positive airway pressure (PAP) device designed to simplify travel for patients living with obstructive sleep apnea (OSA). At half the size of Philips’ previous generation devices, DreamStation Go delivers the same clinically-proven performance and comfort, for reliable, convenient therapy on-the-go.
AMSTERDAM (November 17, 2016)—On World COPD Day, Royal Philips is proud to announce the Breathe Boldly social initiative, which aims to raise awareness for Chronic Obstructive Pulmonary Disease (COPD). Patients with COPD often have trouble breathing, sometimes feeling as though they are breathing through a straw.
